ezetimibe

#134 - James O’Keefe, M.D.: Preventing cardiovascular disease and the risk of too much exercise

Peter Attia MD

A medication that lowers cholesterol by reducing absorption by blocking the Niemann-Pick C1-like 1 (NPC1L1) receptor.

#129 - Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology

Peter Attia MD

A non-statin lipid-lowering drug that blocks intestinal absorption of cholesterol, further depleting hepatic cholesterol pools and increasing LDL receptor expression.

Insights from Sam Harris, Dr. Peter Attia, Ramit Sethi, and Elizabeth Gilbert | The Tim Ferriss Show

Tim Ferriss

A drug used to lower cholesterol, specifically for hyper-absorbers, when statins are not tolerated or insufficient.

#23–Tom Dayspring Part IV of V: statins, Zetia, PCSK9 inhibitors, niacin, cholesterol & the brain

Peter Attia MD

Also known as Zetia, this drug inhibits the Niemann-Pick C1-like protein, reducing cholesterol absorption in the gut and preventing the liver from reabsorbing cholesterol from bile, leading to depletion of liver cholesterol and increased LDL receptor expression.

Exercise, Nutrition, Hormones for Vitality & Longevity | Dr. Peter Attia

Andrew Huberman

A drug that blocks the absorption of cholesterol in the gut by targeting the Neiman-Pick C1-like 1 (NPC1L1) transporter, effective in individuals with high phytosterol levels.

255-Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease, familial hypercholesterolemia

Peter Attia MD

Often added to statin therapy in children with FH to further lower LDL-C.

Supplements I’m Taking, Training for Mental Performance, AI Tools, Recovering from Surgery, and More

Tim Ferriss

A component of the prescription medication Nexloette used for lipid management.

276 ‒ Special episode: Peter on longevity, supplements, protein, fasting, apoB, statins, & more

Peter Attia MD

2024 New Year’s Resolutions, AI Upheavel, & Much More! | The Random Show (4K)

Tim Ferriss

A component of Nexletol, used by the speaker for cholesterol hyper-absorption.

230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more

Peter Attia MD

A non-statin lipid-lowering therapy that can lower LDL cholesterol by about 16 mg/dL, used as an adjunct or in statin-intolerant patients.